Paul D. Rubin's most recent trade in BioAge Labs Inc. was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BioAge Labs Inc. | Paul D. Rubin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |